Anti-tumor necrosis factor agents and COVID-19: A word of caution

Roy Hajjar^{1

2}, Gabriel Chan^{1

2}

Affiliations

¹ Department of Surgery, Hôpital Maisonneuve-Rosemont, Montréal, Québec, Canada. 5415, boulevard de l'Assomption, Montréal, Québec, Canada.
² Division of General Surgery, Université de Montréal, Montréal, Québec, Canada.

Roy Hajjar et al. J Clin Transl Res. 2020.

. 2020 Aug 29;6(3):94-96.

eCollection 2020 Sep 5.

Roy Hajjar^{1

2}, Gabriel Chan^{1

2}

¹ Department of Surgery, Hôpital Maisonneuve-Rosemont, Montréal, Québec, Canada. 5415, boulevard de l'Assomption, Montréal, Québec, Canada.
² Division of General Surgery, Université de Montréal, Montréal, Québec, Canada.

No abstract available

Keywords: COVID-19; anti-TNF; tumor necrosis factor.

Cited by

Oro-facial mucocutaneous manifestations of Coronavirus Disease-2019 (COVID-19): A systematic review.
Fakhruddin KS, Samaranayake LP, Buranawat B, Ngo H. Fakhruddin KS, et al. PLoS One. 2022 Jun 1;17(6):e0265531. doi: 10.1371/journal.pone.0265531. eCollection 2022. PLoS One. 2022. PMID: 35648785 Free PMC article.

1. Tursi A, Vetrone LM, Papa A. Anti-TNF-αlpha Agents in Inflammatory Bowel Disease and Course of Covid-19. Inflamm Bowel Dis. 2020;26:e73. - PMC - PubMed
1. Feldmann M, Maini RN, Woody JN, Holgate ST, Winter G, Rowland M, et al. Trials of Anti-tumour Necrosis Factor Therapy for Covid-19 are Urgently Needed. Lancet. 2020;395:1407–9. - PMC - PubMed
1. Li X, Xu S, Yu M, Wang K, Tao Y, Zhou Y, et al. Risk Factors for Severity and Mortality in Adult Covid-19 Inpatients in Wuhan. J Allergy Clin Immunol. 2020;146:110–8. - PMC - PubMed
1. Lv S, Han M, Yi R, Kwon S, Dai C, Wang R. Anti-TNF-αlpha Therapy for Patients with Sepsis:A Systematic Meta-analysis. Int J Clin Pract. 2014;68:520–8. - PubMed
1. Samaan MA, Bagi P, Casteele NV, D'Haens GR, Levesque BG. An Update on Anti-Tnf Agents in Ulcerative Colitis. Gastroenterol Clin North Am. 2014;43:479–94. - PubMed